logo
Share SHARE
FONT-SIZE Plus   Neg

Repros Therapeutics To Meet With FDA To Discuss Phase 3 Study Design Of Androxal

Repros Therapeutics Inc.(RPRX) Monday said the FDA has scheduled a meeting in May to discuss the design of pivotal Phase 3 efficacy studies for Androxal, as well as the components of the overall drug development program required for NDA submission.

Androxal is an oral therapy intended for the treatment of secondary hypogonadism. Unlike the hormone replacement therapies currently approved to treat this disorder, Androxal restores testicular function resulting in normal synthesis of testosterone and continued spermatogenesis.

Repros said studies using approved testosterone replacement therapies as efficacy and safety comparators have shown the approved treatments result in suppression of important pituitary hormones that drive testicular function down to castration levels in a significant number of men.

Joseph Podolski, president and CEO of The Woodlands, Texas-based company, said," Our goal is to work with the FDA to provide a complete drug dossier for Androxal that exhibits the products' clinical benefit and safety. Depending on FDA comments, we believe we can submit the NDA early in 2014."

RPRX closed Monday's regular trade at $4.35, down $0.15 or 3.33%, on the Nasdaq. In the after-hours, the stock gained $0.01 or 0.23%. Over the past year, the stock traded in a range of $3.34 - $6.85.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
HSBC, the largest bank in the UK, has announced that it will not will relocate its headquarters out of London despite the shocking decision by the UK to leave the European Union. HSBC Chairman Douglas Flint, chairman, speaking at a conference in London, said that HSBC would stick to its plan to keep... Samsung Electronics has launched network unlocked versions of the Galaxy S7 and S7 Edge in the U.S., giving customers the freedom to choose their plans, switch carriers and avoid pre-installed carrier apps. Starting today, the unlocked phones will work on most U.S. GSM and CDMA networks. Online retail giant Amazon.com Inc.'s second annual Prime Day shopping event will take place on Tuesday, July 12, and will become the biggest Amazon sales event ever. It will feature more than 100,000 deals worldwide exclusively for Prime members this year.
comments powered by Disqus
Follow RTT